Page 235 - Read Online

Neurotoxicology 2009;30:497‑521. 231. Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T,
226. Brietzke E, Scheinberg M, Lafer B. Therapeutic potential of Abbott R, Hayhurst H. Cognitive‑behavioural therapy for severe
interleukin‑6 antagonism in bipolar disorder. Med Hypotheses and recurrent bipolar disorders: randomised controlled trial. Br J
2011;76:21‑3. Psychiatry 2006;188:313‑20.
227. Franchini L, Zanardi R, Smeraldi E, Gasperini M. Early onset of 232. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD.
lithium prophylaxis as a predictor of good long‑term outcome. Eur Differential effect of number of previous episodes of affective
Arch Psychiatry Clin Neurosci 1999;249:227‑30. disorder on response to lithium or divalproex in acute mania. Am
228. Kessing LV, Andersen PK, Mortensen PB. Predictors of recurrence J Psychiatry 1999;156:1264‑6.
in affective disorder. A case register study. J Affect Disord 233. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F,
1998;49:101‑8. Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV,
229. Rosa AR, Magalhaes PV, Czepielewski L, Sulzbach MV, Goi PD, Amminger P, McGorry P, Malhi GS. Pathways underlying
Vieta E, Gama CS, Kapczinski F. Clinical staging in bipolar neuroprogression in bipolar disorder: focus on inflammation,
disorder: focus on cognition and functioning. J Clin Psychiatry oxidative stress and neurotrophic factors. Neurosci Biobehav Rev
2014;75:e450‑6. 2011;35:804‑17.
230. Roy‑Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal 234. Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P,
course of recurrent affective illness: life chart data from research Bechdolf A, Moylan S, Malhi GS. Stage managing bipolar disorder.
patients at the NIMH. Acta Psychiatr Scand Suppl 1985;317:1‑34. Bipolar Disord 2014;16:471‑7.

Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015 227